|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Feb―12 |
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19 |
Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, et al. (+3) Lothar Volbracht, Mark Stettner, Christoph Kleinschnitz |
2 |
[GO] |
2022―Dez―09 |
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination |
Simon Faissner, Neele Heitmann, Ricarda Rohling, Ulas Ceylan, Marielena Bongert, Carlos Plaza-Sirvent, et al. (+7) Corinna Marheinecke, Xiomara Pedreiturria, Ilya Ayzenberg, Kerstin Hellwig, Ingo Schmitz, Stephanie Pfaender, Ralf Gold |
3 |
[GO] |
2022―Nov―08 |
Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC) |
Tjalf Ziemssen, Marie Groth, Benedict Rauser, Tobias Bopp |
4 |
[GO] |
2022―Okt―10 |
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System |
Maximilian Pistor, Robert Hoepner, Andreas G.F. Hoepner, Yanan Lin, Simon Jung, Claudio L. Bassetti, et al. (+2) Andrew Chan, Anke Salmen |
5 |
[GO] |
2022―Jul―23 |
Mid-term MRI evaluation reveals microstructural white matter alterations in COVID-19 fully recovered subjects with anosmia presentation |
Laura Pelizzari, Marta Cazzoli, Susanna Lipari, Maria Marcella Laganà, Monia Cabinio, Sara Isernia, et al. (+3) Alice Pirastru, Mario Clerici, Francesca Baglio |
6 |
[GO] |
2022―Jun―25 |
Comment on ‘MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report’ |
Josef Finsterer, Fulvio A Scorza |
7 |
[GO] |
2022―Mai―25 |
Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients |
Paraskevi C. Fragkou, Lina Palaiodimou, Maria Ioanna Stefanou, Aristeidis H. Katsanos, Vaia Lambadiari, Dimitrios Paraskevis, et al. (+9) Elisabeth Andreadou, Dimitra Dimopoulou, Christina Zompola, Panagiotis Ferentinos, Theodoros I. Vassilakopoulos, Anastasia Kotanidou, Petros P. Sfikakis, Sotirios Tsiodras, Georgios Tsivgoulis |
8 |
[GO] |
2022―Mai―18 |
Corrigendum to Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
|
9 |
[GO] |
2022―Apr―23 |
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study |
Tobias Moser, Ciara O’Sullivan, Ferdinand Otto, Wolfgang Hitzl, Georg Pilz, Kerstin Schwenker, et al. (+5) Cornelia Mrazek, Elisabeth Haschke-Becher, Eugen Trinka, Peter Wipfler, Andrea Harrer |
10 |
[GO] |
2022―Jan―19 |
MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report |
Jordi Kühne Escolà, Cornelius Deuschl, Andreas Junker, Fabian Dusse, Refik Pul, Christoph Kleinschnitz, et al. (+2) Martin Köhrmann, Benedikt Frank |
11 |
[GO] |
2021―Dez―08 |
Anti-GFAP-antibody positive postinfectious acute cerebellar ataxia and myoclonus after COVID-19: a case report |
Livia Asan, Stephan Klebe, Christoph Kleinschnitz, Mark Stettner, Martin Köhrmann |
12 |
[GO] |
2021―Dez―07 |
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, et al. (+5) Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
13 |
[GO] |
2021―Aug―14 |
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
Rocco Capuano, Giovanna Donnarumma, Alvino Bisecco, Elena Grimaldi, Miriana Conte, Alessandro d’Ambrosio, et al. (+9) Federica Matrone, Mario Risi, Riccardo Maria Borgo, Manuela Altieri, Federica Giuliano, Nicola Coppola, Massimiliano Galdiero, Gioacchino Tedeschi, Antonio Gallo |
14 |
[GO] |
2021―Jul―23 |
Oropharyngeal swab for SARS-CoV-2 test causing atypical internal carotid artery dissection and stroke in a patient after mild COVID-19 |
Livia Asan, Cornelius Deuschl, Michael Forsting, Christoph Kleinschnitz, Martin Köhrmann |
15 |
[GO] |
2021―Jul―07 |
Persistent decline of hospitalizations for acute stroke and acute coronary syndrome during the second wave of the COVID-19 pandemic in Greece: collateral damage unaffected |
Christos Katsouras, Georgios Tsivgoulis, Michail Papafaklis, Theodore Karapanayiotides, Dimitrios Alexopoulos, Evangelos Ntais, et al. (+13) Georgia Papagiannopoulou, Ioanna Koutroulou, Antonios Ziakas, Georgios Sianos, Antonios Kouparanis, Paraskevi Trivilou, Christos Ballas, Ioanna Samara, Maria Kosmidou, Lina Palaiodimou, Nikolaos Grigoriadis, Lampros K. Michalis, Sotirios Giannopoulos |
16 |
[GO] |
2021―Jul―07 |
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany |
Daniel Richter, Simon Faissner, Dirk Bartig, Lars Tönges, Kerstin Hellwig, Ilya Ayzenberg, et al. (+2) Christos Krogias, Ralf Gold |
17 |
[GO] |
2021―Jun―04 |
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Hela-Felicitas Petereit, Hayrettin Tumani, Uwe K. Zettl |
18 |
[GO] |
2021―Jun―04 |
IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments |
Jürgen Wienands |
19 |
[GO] |
2021―Jun―03 |
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, et al. (+5) Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich |
20 |
[GO] |
2021―Mai―31 |
Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Amanda L. Piquet, John R. Corboy, Timothy L. Vollmer |
21 |
[GO] |
2021―Mai―18 |
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies |
Christoph Friedli, Lara Diem, Helly Hammer, Nicole Kamber, Franziska Suter-Riniker, Stephen Leib, et al. (+4) Andrew Chan, Cédric Hirzel, Robert Hoepner, Anke Salmen |
22 |
[GO] |
2021―Apr―23 |
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, et al. (+5) Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich |
23 |
[GO] |
2021―Feb―27 |
Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection |
Michael Fleischer, Martin Köhrmann, Sebastian Dolff, Fabian Szepanowski, Karsten Schmidt, Frank Herbstreit, et al. (+16) Cansu Güngör, Benjamin Stolte, Katharina Marie Steiner, Christine Stadtler, Joachim Riße, Melanie Fiedler, Gerd Meyer zu Hörste, Anne-K. Mausberg, Clemens Kill, Michael Forsting, Ulrich Sure, Ulf Dittmer, Oliver Witzke, Thorsten Brenner, Christoph Kleinschnitz, Mark Stettner |
24 |
[GO] |
2021―Feb―05 |
Extensive cerebellar involvement and cognitive impairment in COVID-19-associated acute necrotizing encephalopathy |
Dumitru Ciolac, Igor Crivorucica, Eremei Zota, Nadejda Gorincioi, Daniela Efremova, Diana Manea, et al. (+3) Veaceslav Crivorucica, Mihail Ciocanu, Stanislav A. Groppa |
25 |
[GO] |
2020―Dez―10 |
COVID-19 and cerebrovascular diseases: a comprehensive overview |
Georgios Tsivgoulis, Lina Palaiodimou, Ramin Zand, Vasileios Arsenios Lioutas, Christos Krogias, Aristeidis H. Katsanos, et al. (+10) Ashkan Shoamanesh, Vijay K. Sharma, Shima Shahjouei, Claudio Baracchini, Charalambos Vlachopoulos, Rossetos Gournellis, Petros P. Sfikakis, Else Charlotte Sandset, Andrei V. Alexandrov, Sotirios Tsiodras |
26 |
[GO] |
2020―Jun―09 |
Neurological manifestations and implications of COVID-19 pandemic |
Georgios Tsivgoulis, Lina Palaiodimou, Aristeidis H. Katsanos, Valeria Caso, Martin Köhrmann, Carlos Molina, et al. (+12) Charlotte Cordonnier, Urs Fischer, Peter Kelly, Vijay K. Sharma, Amanda C. Chan, Ramin Zand, Amrou Sarraj, Peter D. Schellinger, Konstantinos I. Voumvourakis, Nikolaos Grigoriadis, Andrei V. Alexandrov, Sotirios Tsiodras |
27 |
[GO] |
2020―Mrz―28 |
Potential neurological symptoms of COVID-19 |
Hai-Yang Wang, Xue-Lin Li, Zhong-Rui Yan, Xiao-Pei Sun, Jie Han, Bing-Wei Zhang |